INKmune

INKmune · Inmune Bio, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for INKmune, covering 2026-02-27 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML [Phase 1]